Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction.
about
Cellular and molecular basis of deiodinase-regulated thyroid hormone signalingAblation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractilitySelenium and its supplementation in cardiovascular disease--what do we know?Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes.Role of inotropic agents in the treatment of heart failure.Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling.Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes.Thyroid and the heartThyroid hormone signaling in energy homeostasis and energy metabolism.Decreased cardiac SERCA2 expression, SR Ca uptake, and contractile function in hypothyroidism are attenuated in SERCA2 overexpressing transgenic rats.Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in miceShort term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats.MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type IIIDifferential expression of sarcolipin protein during muscle development and cardiac pathophysiologyCardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?Cardiac hypertrophy and thyroid hormone signalingAmerican Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.Essential role of TEA domain transcription factors in the negative regulation of the MYH 7 gene by thyroid hormone and its receptors.New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?Restoration of thyroid hormone balance: a game changer in the treatment of heart failure?Role of thyroid hormones in ventricular remodeling.Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.Cardiac Thyroid Hormone Metabolism and Heart Failure.Heart selenoproteins status of metabolic syndrome-exposed pups: A potential target for attenuating cardiac damage.Thyroid hormone and cardiac disease: from basic concepts to clinical application.Selenoproteins and cardiovascular stress.Myocardial Inactivation of Thyroid Hormones in Patients with Aortic Stenosis.Myocardial Induction of Type 3 Deiodinase in Dilated Cardiomyopathy.Angiotensin II does not influence expression of sarcoplasmic reticulum Ca2 + ATPase in atrial myocytes.
P2860
Q24648381-B3ACE96A-38B5-417D-B9FE-8F1114D05CE5Q24679092-17022521-020F-4331-B20D-8F8879641D23Q28084516-0B81D4B1-8706-49DE-B8A8-6C16DD518524Q33745811-A0D26ED8-8CAC-42D8-9AD2-E13ADAC3DAAEQ33816527-40C614F5-200B-43E1-A643-4B8259E6391EQ34369275-EBF02C55-0EAF-4962-BC3C-C70D50CDF5F0Q34469539-5899FECB-45F7-4BD7-A249-D22579CBECF0Q35054125-D7AA28CD-FA09-414E-BD88-F9C6B066CA3BQ35671563-16B27DAE-84BA-4C7E-B587-B753017401CDQ35825891-0E62B05E-FA6E-448D-8273-D863652FF7C3Q35970123-C57E9610-0379-40B0-AC29-FB0D953B1636Q36449314-DA545CB6-9E56-4CCE-A344-3F5F1F33FE42Q36665561-58999F8B-8920-4B76-BA18-5D13FA5CA8D3Q37252432-EF95F33B-2CA8-4F2F-96CD-2C29C13B36A7Q37358096-279ACAE8-A876-4337-93AD-F827CDAD3395Q37363137-A3D15452-95AC-478D-B52F-DEFDB1636805Q37460346-CA7D425C-9C3C-4D3B-AACE-6A3B090CC356Q37732104-71D2F1CD-2811-49A0-9740-DAB2B3D29FF2Q37776431-3E6BEDEA-786A-4A16-B1A2-FCB7A7E9A506Q38266177-FE9996CB-5C99-494C-B1D3-70B590B74EDDQ38285918-BCDD75F4-C730-49F4-BD62-FC23B0EC3264Q38295801-010FF898-3747-41EF-AB68-1D66A099162DQ38635787-75DE1E8D-21EA-491D-BBEF-049B80FA8E9CQ38831748-D58022C7-AE04-425F-8BDD-E0416F50ECC3Q41870176-8EA64A83-CBF2-420B-9766-B6EAECDA8A17Q50192080-7EE73AC9-6BE2-412E-9987-786E8E154BA0Q50949268-1BB7297B-4130-4509-8476-49D5F938CF5EQ52889480-EFFACFBF-BD6A-4679-9111-F9806E580BBCQ54472831-147BA162-DAF8-4CAB-A9A4-E0012CC81A67
P2860
Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@ast
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@en
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@nl
type
label
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@ast
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@en
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@nl
prefLabel
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@ast
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@en
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@nl
P2093
P2860
P356
P1476
Cardiac-specific elevations in ...... d-induced cardiac dysfunction.
@en
P2093
Alan D Wickenden
Anthony O Gramolini
Benoit-Gilles Kerfant
David H Maclennan
Donald St Germain
Gabriella Morreale de Escobar
Gavin Y Oudit
Maria Giovanna Trivieri
Peter H Backx
P2860
P304
P356
10.1073/PNAS.0601072103
P407
P577
2006-04-04T00:00:00Z